PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2016

IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 26783184 ↗2016Reported benefit

IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo.

MouseChemical/toxinIL-36R-deficient and Myd88-deficient miceapplied to established experimental intestinal wounds

Model: Acute dextran sodium sulfate colitis and experimental intestinal mucosal wounds

Defective IL-36R signalling increased susceptibility to dextran sodium sulfate colitis and impaired wound healing, while treating experimental intestinal wounds with IL-36R ligands significantly accelerated mucosal healing in vivo.

Extraction: extract · Supplied extraction confidence: 0.65. Machine-extracted fields require source verification.